Literature DB >> 19889783

Germinal center B cells latently infected with Epstein-Barr virus proliferate extensively but do not increase in number.

Jill E Roughan1, Charles Torgbor, David A Thorley-Lawson.   

Abstract

In this study we show that in long-term persistent infection, Epstein-Barr virus (EBV)-infected cells undergoing a germinal center (GC) reaction in the tonsils are limited to the follicles and proliferate extensively. Despite this, the absolute number of infected cells per GC remains small (average of 3 to 4 cells per germinal center; range, 1 to 9 cells), and only about 38 to 55% (average, 45%) of all GCs carry infected cells. The data fit a model where, on average, cells in the GC divide approximately three times; however, only one progeny cell survives to undergo a further three divisions. Thus, a fraction of cells undergo multiple rounds of division without increasing in numbers; i.e., they die at the same rate that they are dividing. We conclude that EBV-infected cells in the GC undergo the extensive proliferation characteristic of GC cells but that the absolute number is limited either by the immune response or by the availability of an essential survival factor. We suggest that this behavior is a relic of the mechanism by which EBV establishes persistence during acute infection. Lastly, the expression of the viral latent protein LMP1 in GC B cells, unlike in vitro, does not correlate directly with the expression of bcl-2 or bcl-6. This emphasizes our claim that observations made regarding the functions of EBV proteins in cell lines or in transgenic mice should be treated with skepticism unless verified in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19889783      PMCID: PMC2798379          DOI: 10.1128/JVI.01780-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  THE INCUBATION PERIOD OF INFECTIOUS MONONUCLEOSIS.

Authors:  R J HOAGLAND
Journal:  Am J Public Health Nations Health       Date:  1964-10

2.  Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo.

Authors:  Dimitris Panagopoulos; Panayiotis Victoratos; Maria Alexiou; George Kollias; George Mosialos
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

3.  Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo.

Authors:  Lauri L Laichalk; David A Thorley-Lawson
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils.

Authors:  S David Hudnall; Yimin Ge; Longxing Wei; Ning-Ping Yang; Hui-Quin Wang; Tiansheng Chen
Journal:  Mod Pathol       Date:  2005-04       Impact factor: 7.842

5.  A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses.

Authors:  Adam Grundhoff; Christopher S Sullivan; Don Ganem
Journal:  RNA       Date:  2006-03-15       Impact factor: 4.942

6.  Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals.

Authors:  R G Caldwell; J B Wilson; S J Anderson; R Longnecker
Journal:  Immunity       Date:  1998-09       Impact factor: 31.745

7.  EBV persistence in memory B cells in vivo.

Authors:  G J Babcock; L L Decker; M Volk; D A Thorley-Lawson
Journal:  Immunity       Date:  1998-09       Impact factor: 31.745

8.  Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells.

Authors:  Tatyana A Souza; B David Stollar; John L Sullivan; Katherine Luzuriaga; David A Thorley-Lawson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

9.  Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.

Authors:  Michelle A Swanson-Mungerson; Robert G Caldwell; Rebecca Bultema; Richard Longnecker
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

10.  Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed.

Authors:  Xuezhong Cai; Alexandra Schäfer; Shihua Lu; John P Bilello; Ronald C Desrosiers; Rachel Edwards; Nancy Raab-Traub; Bryan R Cullen
Journal:  PLoS Pathog       Date:  2006-03-24       Impact factor: 6.823

View more
  32 in total

Review 1.  EBV Persistence--Introducing the Virus.

Authors:  David A Thorley-Lawson
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

2.  LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activation.

Authors:  Frederik J Verweij; Monique A J van Eijndhoven; Erik S Hopmans; Tineke Vendrig; Tom Wurdinger; Ellen Cahir-McFarland; Elliott Kieff; Dirk Geerts; Rik van der Kant; Jacques Neefjes; Jaap M Middeldorp; D Michiel Pegtel
Journal:  EMBO J       Date:  2011-04-28       Impact factor: 11.598

3.  Epstein-Barr virus IL-10 engages IL-10R1 by a two-step mechanism leading to altered signaling properties.

Authors:  Sung Il Yoon; Brandi C Jones; Naomi J Logsdon; Bethany D Harris; Srilalitha Kuruganti; Mark R Walter
Journal:  J Biol Chem       Date:  2012-06-12       Impact factor: 5.157

Review 4.  Viral-associated lymphoid proliferations.

Authors:  Stefania Pittaluga
Journal:  Semin Diagn Pathol       Date:  2013-03-26       Impact factor: 3.464

Review 5.  The pathogenesis of Epstein-Barr virus persistent infection.

Authors:  David A Thorley-Lawson; Jared B Hawkins; Sean I Tracy; Michael Shapiro
Journal:  Curr Opin Virol       Date:  2013-05-15       Impact factor: 7.090

Review 6.  Epstein-Barr virus: more than 50 years old and still providing surprises.

Authors:  Lawrence S Young; Lee Fah Yap; Paul G Murray
Journal:  Nat Rev Cancer       Date:  2016-09-30       Impact factor: 60.716

7.  Persistence of Epstein-Barr virus in self-reactive memory B cells.

Authors:  Sean I Tracy; Kristina Kakalacheva; Jan D Lünemann; Katherine Luzuriaga; Jaap Middeldorp; David A Thorley-Lawson
Journal:  J Virol       Date:  2012-09-05       Impact factor: 5.103

Review 8.  Cytomegalovirus latency and reactivation: recent insights into an age old problem.

Authors:  Liane Dupont; Matthew B Reeves
Journal:  Rev Med Virol       Date:  2015-11-17       Impact factor: 6.989

9.  T Cell-Intrinsic Interferon Regulatory Factor 1 Expression Suppresses Differentiation of CD4+ T Cell Populations That Support Chronic Gammaherpesvirus Infection.

Authors:  C N Jondle; K E Johnson; W P Mboko; V L Tarakanova
Journal:  J Virol       Date:  2021-08-04       Impact factor: 5.103

10.  Low-Density Lipoprotein Receptor Suppresses the Endogenous Cholesterol Synthesis Pathway To Oppose Gammaherpesvirus Replication in Primary Macrophages.

Authors:  C A Aurubin; D A Knaack; D Sahoo; V L Tarakanova
Journal:  J Virol       Date:  2021-08-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.